Teikoku Pharma has a proven track record of working with companies around the world to successfully research, develop, register, manufacture and market innovative transdermal products that have a major presence in the US, Japan and Europe, including:.

Flector – in partnership with IBSA in 1991

Versatis – in partnership with Grüenthal in 2001

Envela – 510K approved occlusive dressing for use in the management of psoriasis and the protection of psoriatic plaques